New therapy = new code – Ophthalmology Management

New therapies always engender questions about reimbursement — and often, new codes. Dexamethasone ophthalmic insert falls into this category.

This article addresses the following questions:

• What is dexamethasone ophthalmic insert?
• How is the procedure coded?
• How is the supply coded?
• Is it covered?
• Do HOPDs or ASCs get a facility payment?
• What about the surgeon’s reimbursement?
• Do Medicare copayments apply?
• Does using dexamethasone ophthalmic insert affect MIPS scores?

This article was published in Ophthalmology Management’s Coding & Reimbursement column, which is written by Corcoran’s Executive Vice-President, Suzanne Corcoran, COE. To view the entire article in Ophthalmology Management, click on the link below:

https://www.ophthalmologymanagement.com/issues/2019/september-2019/coding-amp;-reimbursement